The Latest State Actions to Tackle Rx Prices, and What’s Next?
Wednesday, August 21, 8 am – 4 pm
This preconference provides a unique opportunity to examine what states can do to lower drug prices, the challenges they face, and strategies to overcome them. Topics include pharmacy benefit managers, drug importation from Canada, affordability review boards, Medicaid models, and more. Participants include legislators, governors’ staff, state employee health benefit administrators, Medicaid officials, and attorneys general/staff, as well as academics, advocates, industry representatives, and interested stakeholders wanting to connect with the people, tools, and resources needed to achieve successful drug pricing reforms.
View the agenda.
Cosponsored by AARP and supported by Arnold Ventures.
Pharmacy Management Consultants
Vice President for Federal Health & Family Government Affairs Office
Associate Attorney General for Enforcement, Litigation and Investigations
Connecticut Office of the Attorney General
Senior Policy Advisor
Office of Governor Jared Polis
Senior Health Policy Researcher
The Source on Healthcare Price and Competition at UC Hastings College of the Law
Chair, New York State Assembly Committee on Health
Chief Data Officer
California Office of Statewide Health Planning and Development
Maine State Senate
Chief of Staff to the Medicaid Director
New York State Department of Health
Executive Office of Health & Human Services
Maine Health Data Organization
Catherine Kirk Robins
Maryland Citizens' Health Initiative
Policy and Legal Director
Office of the Maine Senate President
Fee for Service Rates Manager
Colorado Department of Health Care Policy and Financing
Senior Pharmacy Advisor
Department of Health and Human Services